Rhythm Pharmaceuticals Inc (RYTM)
39.78
+0.96
(+2.49%)
USD |
NASDAQ |
Apr 30, 16:00
39.78
0.00 (0.00%)
After-Hours: 17:01
Rhythm Pharmaceuticals Revenue (TTM): 77.43M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 77.43M |
| September 30, 2023 | 61.98M |
| June 30, 2023 | 43.76M |
| March 31, 2023 | 33.61M |
| December 31, 2022 | 23.64M |
| Date | Value |
|---|---|
| September 30, 2022 | 16.66M |
| June 30, 2022 | 13.41M |
| March 31, 2022 | 4.617M |
| December 31, 2021 | 3.154M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
3.154M
Minimum
Dec 2021
77.43M
Maximum
Dec 2023
30.92M
Average
23.64M
Median
Dec 2022
Revenue (TTM) Benchmarks
| Pfizer Inc | 58.50B |
| Insmed Inc | 305.21M |
| Altimmune Inc | 0.426M |
| Regeneron Pharmaceuticals Inc | 13.12B |
| Viking Therapeutics Inc | -- |